Company logo

HALO - Halozyme Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

HALO price evolution
HALO
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $118.37 $274.23 $221.16 $96.88
Short term investments $217.63 $209.06 $127.11 $179.22
Net receivables $234.21 $217.32 $246.18 $194.88
Inventory $127.6 $128.92 $132.41 $107.52
Total current assets $746.42 $879.01 $765.75 $615.02
Long term investments
Property, plant & equipment $74.94 $74.67 $74.56 $77.96
Goodwill & intangible assets $889.7 $907.46 $927.8 $945.04
Total noncurrent assets $986.85 $1013.66 $1044.69 $1084.43
Total investments $217.63 $209.06 $127.11 $179.22
Total assets $1733.27 $1892.66 $1810.44 $1699.45
Current liabilities
Accounts payable $11.82 $19.32 $10.12 $8.7
Deferred revenue $2.92 $3.1 $5.5
Short long term debt
Total current liabilities $112.49 $115.19 $116.39 $91.92
Long term debt $1499.25 $1497.62 $1496 $1494.38
Total noncurrent liabilities $1536.97 $1528.3 $1543.01 $1541.68
Total debt $1499.25 $1497.62 $1496 $1494.38
Total liabilities $1649.46 $1643.48 $1659.41 $1633.6
Shareholders' equity
Retained earnings $90.55 $222.28 $140.45 $65.69
Other shareholder equity -$9.28 $1.23 -$1.61 $0.02
Total shareholder equity $83.81 $249.18 $151.03 $65.85
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $118.37 $234.69 $119.22 $148.2
Short term investments $217.63 $128.6 $622.2 $220.31
Net receivables $234.21 $231.07 $90.97 $97.73
Inventory $127.6 $100.12 $53.91 $60.75
Total current assets $746.42 $739.01 $926.29 $554.76
Long term investments
Property, plant & equipment $74.94 $75.57 $8.79 $10.59
Goodwill & intangible assets $889.7 $955.7
Total noncurrent assets $986.85 $1102.5 $178.14 $25.16
Total investments $217.63 $128.6 $622.2 $220.31
Total assets $1733.27 $1841.51 $1104.43 $579.92
Current liabilities
Accounts payable $11.82 $17.69 $1.54 $1.93
Deferred revenue $5.5 $4.28 $5.77
Short long term debt $13.33 $89.42 $397.23
Total current liabilities $112.49 $130.79 $117.15 $421.38
Long term debt $1499.25 $1492.77 $787.25
Total noncurrent liabilities $1536.97 $1540.92 $790.33 $7.49
Total debt $1499.25 $1506.1 $876.67 $397.23
Total liabilities $1649.46 $1671.71 $907.48 $428.88
Shareholders' equity
Retained earnings $90.55 $143.22 -$58.91 -$474.59
Other shareholder equity -$9.28 -$0.92 -$0.62 $0.02
Total shareholder equity $83.81 $169.8 $196.95 $151.05
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $230.04 $216.03 $221.04 $162.14
Cost of revenue $52.3 $54.82 $50.07 $35.17
Gross Profit $177.74 $161.21 $170.97 $126.97
Operating activities
Research & development $21.34 $17.32 $19.73 $17.98
Selling, general & administrative $37.61 $35.27 $38.95 $37.36
Total operating expenses $76.71 $72.93 $76.51 $73.17
Operating income $101.03 $88.28 $94.46 $53.8
Income from continuing operations
EBIT $106.39 $106.27 $97.65 $56.78
Income tax expense $15.79 $19.92 $18.4 $12.62
Interest expense $5.22 $4.5 $4.49 $4.54
Net income
Net income $85.39 $81.84 $74.75 $39.62
Income (for common shares) $85.39 $81.84 $74.75 $39.62
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $829.25 $660.12 $443.31 $267.59
Cost of revenue $192.36 $139.3 $81.41 $43.37
Gross Profit $636.89 $520.81 $361.9 $224.23
Operating activities
Research & development $76.36 $66.61 $35.67 $34.24
Selling, general & administrative $149.18 $143.53 $50.32 $45.74
Total operating expenses $299.32 $253.28 $86 $79.97
Operating income $337.57 $267.53 $275.9 $144.25
Income from continuing operations
EBIT $367.09 $265.87 $256.04 $149.68
Income tax expense $66.73 $46.79 -$154.19 $0.22
Interest expense $18.76 $16.95 $7.53 $20.38
Net income
Net income $281.59 $202.13 $402.71 $129.09
Income (for common shares) $281.59 $202.13 $402.71 $129.09
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $85.39 $81.84 $74.75 $39.62
Operating activities
Depreciation $20.69 $23.08 $20.63 $20.46
Business acquisitions & disposals
Stock-based compensation $9.66 $9.37 $9.62 $7.97
Total cash flows from operations $102.35 $132.41 $66.84 $86.96
Investing activities
Capital expenditures -$2.6 -$2.94 $1.62 -$11.38
Investments -$5.7 -$80.51 $53.37 -$48.78
Total cash flows from investing -$8.29 -$83.45 $54.99 -$60.16
Financing activities
Dividends paid
Sale and purchase of stock -$249.92 $4.1 $2.45 -$151.13
Net borrowings -$13.48
Total cash flows from financing -$249.92 $4.1 $2.45 -$164.61
Effect of exchange rate
Change in cash and equivalents -$155.86 $53.06 $124.28 -$137.81
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $281.59 $202.13 $402.71 $129.09
Operating activities
Depreciation $84.86 $49.64 $3 $3.28
Business acquisitions & disposals -$999.12
Stock-based compensation $36.62 $24.4 $20.82 $17.2
Total cash flows from operations $388.57 $240.11 $299.44 $55.45
Investing activities
Capital expenditures -$15.29 $21.2 -$1.46 -$1.43
Investments -$81.61 $490.92 -$404.83 $79.78
Total cash flows from investing -$96.91 -$487 -$406.29 $78.35
Financing activities
Dividends paid
Sale and purchase of stock -$394.5 -$185.95 -$337.52 -$86.72
Net borrowings -$13.48 $617.44 $415.39 -$19.56
Total cash flows from financing -$407.99 $362.37 $77.86 -$106.28
Effect of exchange rate
Change in cash and equivalents -$116.33 $115.48 -$28.98 $27.52
Fundamentals
Market cap $5.16B
Enterprise value $6.54B
Shares outstanding 126.77M
Revenue $829.25M
EBITDA $451.95M
EBIT $367.09M
Net Income $281.59M
Revenue Q/Q 26.75%
Revenue Y/Y 25.62%
P/E ratio 18.31
EV/Sales 7.88
EV/EBITDA 14.47
EV/EBIT 17.81
P/S ratio 6.22
P/B ratio 55.40
Book/Share 0.73
Cash/Share 0.93
EPS $2.22
ROA 15.78%
ROE 204.84%
Debt/Equity 19.68
Net debt/EBITDA 3.39
Current ratio 6.64
Quick ratio 5.50